Vol 78, No 4 (2020)
Review paper
Published online: 2020-03-24

open access

Page views 2156
Article views/downloads 2167
Get Citation

Connect on Social Media

Connect on Social Media

Current challenges in the diagnosis and treatment of cardiac myxoma

George Samanidis, Mazen Khoury, Marina Balanika, Despina N. Perrea
Pubmed: 32207702
Kardiol Pol 2020;78(4):269-277.

Abstract

Cardiac myxoma is the most common benign cardiac tumor. It is located in the left atrium and typically arises from the foramen ovale in approximately 75% of the general patient population, in the right atrium in 23%, and in the ventricles in only 2%. Symptoms depend on its size, mobility, and relation to surrounding cardiac structures. Neurological complications resulting from cardiac myxoma are seen in 20% to 25% of patients. Molecular genetic studies show that the condition can be inherited in Carney complex due to mutations of the PRKAR1A gene. Cardiac myxoma resection is a cardiac surgery with a low complication rate and the 30‑day mortality of up to 10%. Recurrence may be observed months or years after surgery, and its rate is approximately 5%. Long‑term follow‑up with transthoracic echocardiography is needed in all patients after tumor resection. This review summarizes the available data on cardiac myxoma and, in particular, issues relating to diagnosis and treatment.

Article available in PDF format

View PDF Download PDF file



Polish Heart Journal (Kardiologia Polska)